NP Thyroid 60 NDC 76420-568

NDC codes

FDA NDC Directory

Product NDC (as listed)76420-568Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76420-0568Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
76420-568-01	76420056801	100 TABLET in 1 BOTTLE (76420-568-01)Marketed from May 16, 2023
76420-568-30	76420056830	30 TABLET in 1 BOTTLE (76420-568-30)Marketed from May 16, 2023
76420-568-60	76420056860	60 TABLET in 1 BOTTLE (76420-568-60)Marketed from May 16, 2023
76420-568-90	76420056890	90 TABLET in 1 BOTTLE (76420-568-90)Marketed from May 16, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): NP Thyroid 60
Generic name (nonproprietary): levothyroxine, liothyronine
Active ingredients: Levothyroxine — 38 ug/1Liothyronine — 9 ug/1
Dosage form: Tablet
Route: Oral
Labeler: Asclemed USA, Inc.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Nov 11, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Thyroxine (Chemical structure)Triiodothyronine (Chemical structure)
Identifiers: Product ID 76420-568_fbc96c09-340c-aa6b-e053-6294a90ae779SPL ID fbc96c09-340c-aa6b-e053-6294a90ae779SPL set ID 648d1fcb-d816-4e40-9b5e-beac8ab766adRxCUI 313391, 1724481UNII Q51BO43MG4, 06LU7C9H1V
Pharmacologic class: l-Thyroxine; l-Triiodothyronine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N476420056801 followed by a unit qualifier and the quantity

Package 76420-0568-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 16, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE: NP Thyroid® tablets (thyroid tablets, USP) are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WA…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)